Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycle
Replacing GnRH agonist cotreatment for the prevention of a premature rise in LH during ovarian stimu...
In a clinical retrospective study, a follow-up of hypothalamo-amenorrheic patients treated firstly w...
ObjectiveTo assess the relationships between serum antimüllerian hormone (AMH) and ovarian response ...
Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-rele...
OBJECTIVE: to investigate the efficacy of a gonadotropin-releasing hormone analogue (GN-RH-a) in com...
study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertilit...
textabstractGonadotrophin-releasing hormone agonists (GnRHa) are widely used in in-vitro ...
Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrho...
Can controlled ovarian stimulation with low-dose human menopausal gonadotrophin (hMG) improve the cl...
Objective: To explore luteal phase hormone profiles in patients stimulated with recombinant FSH and ...
Ovarian stimulation in a gonadotropin-releasing hormone (GnRH) antagonist protocol with the use of G...
Fractured zona oocytes in in-vitro fertilization cycles stimulated with gonadotrophin-releasing horm...
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intr...
In the present study, subtle serum progesterone rise (≤ 1.1 ng/ml) during the late follicular phase ...
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is com...
Replacing GnRH agonist cotreatment for the prevention of a premature rise in LH during ovarian stimu...
In a clinical retrospective study, a follow-up of hypothalamo-amenorrheic patients treated firstly w...
ObjectiveTo assess the relationships between serum antimüllerian hormone (AMH) and ovarian response ...
Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-rele...
OBJECTIVE: to investigate the efficacy of a gonadotropin-releasing hormone analogue (GN-RH-a) in com...
study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertilit...
textabstractGonadotrophin-releasing hormone agonists (GnRHa) are widely used in in-vitro ...
Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrho...
Can controlled ovarian stimulation with low-dose human menopausal gonadotrophin (hMG) improve the cl...
Objective: To explore luteal phase hormone profiles in patients stimulated with recombinant FSH and ...
Ovarian stimulation in a gonadotropin-releasing hormone (GnRH) antagonist protocol with the use of G...
Fractured zona oocytes in in-vitro fertilization cycles stimulated with gonadotrophin-releasing horm...
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intr...
In the present study, subtle serum progesterone rise (≤ 1.1 ng/ml) during the late follicular phase ...
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is com...
Replacing GnRH agonist cotreatment for the prevention of a premature rise in LH during ovarian stimu...
In a clinical retrospective study, a follow-up of hypothalamo-amenorrheic patients treated firstly w...
ObjectiveTo assess the relationships between serum antimüllerian hormone (AMH) and ovarian response ...